Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Vose J, Armitage J, Weisenburger D et al (2008) International peripheral T‑cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124–4130
2. Greer J, Kinney M, Collins R et al (1991) Clinical features of 31 patients with Ki‑1 anaplastic large-cell lymphoma. J Clin Oncol 9:539–547
3. Swerdlow S, Campo E, Harris N et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. World Health Organization, Geneva
4. Garces de los Fayos Alonso I, Liang HC, Turner SD et al (2018) The role of activator protein‑1 (AP-1) family members in CD30-positive lymphomas. Cancers (Basel) 10:E93
5. Crescenzo R, Abate F, Lasorsa E et al (2015) Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell 27:516–532